Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 7, 2006, Pages 1009-1020

  Arango Rodriguez, Martha L ^a,b   Navarro Quiroga, Ivan ^c   Gonzalez Barrios, Juan A ^a   Martinez Arguelles, Daniel B ^a   Bannon, Michael J ^d   Kouri, Juan ^a   Forgez, Patricia ^e   Rostene, William ^e   Garcia Villegas, Refugio ^a   Jimenez, Ismael ^a   Martinez Fong, Daniel ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c WESLEYAN UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSERM   (France)

Author keywords

DNA condensation; Fusogenic peptide; Gene delivery; Karyophilic peptide; Nuclear localization signal; Receptor mediated endocytosis

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; FUSOGENIC PEPTIDE; NEUROTENSIN DERIVATIVE; NEUROTENSIN POLYPLEX; NEUROTENSIN RECEPTOR; PEPTIDE DERIVATIVE; PLASMID DNA; POLYLYSINE; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONJUGATE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; ELECTROPHORESIS; ENDOCYTOSIS; GENE TRANSFER; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT;

ANIMALS; BIOPHYSICS; CELL LINE, TUMOR; DOPAMINE; GENETIC TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; NEURONS; NEUROTENSIN; NUCLEAR LOCALIZATION SIGNALS; PYRAZOLES; QUINOLINES; RATS; RATS, WISTAR; TRANSFECTION;

EID: 33745024299     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.02.021     Document Type: Article

References (45)

1. Demeneix B., Hassani Z., and Behr J.P. Towards multifunctional synthetic vectors. Curr. Gene Ther. 4 (2004) 445-455
2. Kollen W., Erbacher P., Midoux P., Roche A.C., Monsigny M., Glick M.C., and Scanlin T.F. Glycosylated polylysines-Nonviral vectors for gene transfer into cystic fibrosis airway epithelial cells. Chest 111 (1997) S95-S96
3. Martinez-Fong D., and Navarro-Quiroga I. Synthesis of a non-viral vector for gene transfer via the high-affinity neurotensin receptor. Brain Res. Protoc. 6 (2000) 13-24
4. Martinez-Fong D., Navarro-Quiroga I., Ochoa I., Alvarez-Maya I., Meraz M.A., Luna J., and Arias-Montano J.A. Neurotensin-SPDP-poly-l-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells. Mol. Brain Res. 69 (1999) 249-262
5. Alvarez-Maya I., Navarro-Quiroga I., Meraz-Rios M.A., Aceves J., and Martinez-Fong D. In vivo gene transfer to dopamine neurons of rat substantia nigra via the high-affinity neurotensin receptor. Mol. Med. 7 (2001) 186-192
6. Navarro-Quiroga I., Gonzalez-Barrios J.A., Barron-Moreno F., Gonzalez-Bernal V., Martinez-Arguelles D.B., and Martinez-Fong D. Improved neurotensin-vector-mediated gene transfer by the coupling of hemagglutinin HA2 fusogenic peptide and Vp1 SV40 nuclear localization signal. Mol. Brain Res. 105 (2002) 86-97
7. Vandenbulcke F., Nouel D., Vincent J.P., Mazella J., and Beaudet A. Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. J. Cell Sci. 113 (2000) 2963-2975
8. Chan C.K., and Jans D.A. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol. Cell Biol. 80 (2002) 119-130
9. Golan R., Pietrasanta L.I., Hsieh W., and Hansma H.G. DNA toroids: stages in condensation. Biochemistry 38 (1999) 14069-14076
10. Conwell C.C., Vilfan I.D., and Hud N.V. Controlling the size of nanoscale toroidal DNA condensates with static curvature and ionic strength. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9296-9301
11. J.A. Gonzalez-Barrios, M. Bannon, V. Anaya Martínez, G. Flores, I. Navarro-Quiroga, L.E. Trudeau, J. Aceves, and D. Martinez-Fong, Polyfection of HGDNF to Nigral Dopamine Neurons Ameliorates Hemiparkinsonism in the rat, Program No. 299.15. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online. 33th Annual meeting of Society for Neurosciences. (2003) New Orleans, LA. USA.
12. Sacchetti P., Brownschidle L., Granneman J., and Bannon M. Characterization of the 5′-flanking region of the human dopamine transporter gene. Mol. Brain Res. 74 (1999) 167-174
13. Cusack B., Stanton T., and Richelson E. Developmental regulation of neurotensin receptor expression and function in murine neuroblastoma clone N1E-115. Eur. J. Pharmacol. 206 (1991) 339-342
14. Toy-Miou-Leong M., Cortes C.L., Beaudet A., Rostene W., and Forgez P. Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation. J. Biol. Chem. 279 (2004) 12636-12646
15. Dubruel P., Dekie L., Christiaens B., Vanloo B., Rosseneu M., Van De K.J., Mannisto M., Urtti A., and Schacht E. Poly-l-glutamic acid derivatives as multifunctional vectors for gene delivery. Part B. Biological evaluation. Biomacromolecules 4 (2003) 1177-1183
16. Checler F., Barelli H., Kitabgi P., and Vincent J.P. Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase. Biochimie 70 (1988) 75-82
17. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, New York
18. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J.C., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A., Pelaprat D., Labbe-Jullie C., Mazella J., Soubrie P., Maffrand J.P., Rostene W., Kitabgi P., and Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 65-69
19. Faure M.P., Alonso A., Nouel D., Gaudriault G., Dennis M., Vincent J.P., and Beaudet A. Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain. J. Neurosci. 15 (1995) 4140-4147
20. Castel M.N., Beaudet A., and Laduron P.M. Retrograde axonal-transport of neurotensin in rat nigrostriatal dopaminergic-neurons-Modulation during aging and possible physiological-role. Biochem. Pharmacol. 47 (1994) 53-62
21. Wang J., and Bannon M.J. Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J. Neurochem. 93 (2005) 474-482
22. Boudin H., Pelaprat D., Rostene W., Pickel V.M., and Beaudet A. Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra. J. Neurosci. 18 (1998) 8473-8484
23. Madhusoodanan M., and Lazaridis T. Investigation of pathways for the low-pH conformational transition in influenza hemagglutinin. Biophys. J. 84 (2003) 1926-1939
24. Swalley S.E., Baker B.M., Calder L.J., Harrison S.C., Skehel J.J., and Wiley D.C. Full-length influenza hemagglutinin HA(2) refolds into the trimeric low-pH-induced conformation. Biochemistry 43 (2004) 5902-5911
25. Mastrobattista E., Koning G.A., van Bloois L., Filipe A.C.S., Jiskoot W., and Storm G. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J. Biol. Chem. 277 (2002) 27135-27143
26. Ishii N., Nakanishi A., Yamada M., Macalalad M.H., and Kasamatsu H. Functional complementation of nuclear targeting-defective mutants of Simian-virus-40 structural proteins. J. Virol. 68 (1994) 8209-8216
27. Ishii N., Minami N., Chen E.Y., Medina A.L., Chico M.M., and Kasamatsu H. Analysis of a nuclear localization signal of simian virus 40 major capsid protein Vp1. J. Virol. 1996 (1996) 1317-1322
28. Aris A., and Villaverde A. Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem. Biophys. Res. Commun. 304 (2003) 625-631
29. Hwang S.J., Bellocq N.C., and Davis M.E. Effects of structure of beta-cyclodextrin-containing polymers on gene delivery. Bioconjug. Chem. 12 (2001) 280-290
30. Fischer D., Dautzenberg H., Kunath K., and Kissel T. Poly(diallyldimethylammonium chlorides) and their N-methyl-N-vinylacetamide copolymer-based DNA-polyplexes: role of molecular weight and charge density in complex formation, stability, and in vitro activity. Int. J. Pharm. 280 (2004) 253-269
31. Pack D.W., Hoffman A.S., Pun S., and Stayton P.S. Design and development of polymers for gene delivery. Nat. Rev., Drug Discov. 4 (2005) 581-593
32. Martinez-Fong D., Mullersman J.E., Purchio A.F., Armernariz-Borunda J., and Martinez-Hernandez A. Nonenzymatic glycosylation of poly-l-lysine: a new tool for targeted gene delivery. Hepatology 20 (1994) 1602-1608
33. Collins L., Asuni A.A., Anderton B.H., and Fabre J.W. Efficient gene delivery to primary neuron cultures using a synthetic peptide vector system. J. Neurosci. Methods 125 (2003) 113-120
34. Gossen M., and Bujard H. Tight control of gene-expression in mammalian-cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
35. Ginhoux F., Turbant S., Gross D.A., Poupiot J., Marais T., Lone Y., Lemonnier F.A., Firat H., Perez N., Danos O., and Davoust J. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol. Ther. 10 (2004) 279-289
36. Croll S.D., Suri C., Compton D.L., Simmons M.V., Yancopoulos G.D., Lindsay R.M., Wiegand S.J., Rudge Y.S., and Scharfman H.E. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93 (1999) 1491-1506
37. Georgievska B., Kirik D., and Bjorklund A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177 (2002) 461-474
38. Rosenblad C., Georgievska B., and Kirik D. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci. 17 (2003) 260-270
39. Toniatti C., Bujard H., Cortese R., and Ciliberto G. Gene therapy progress and prospects: transcription regulatory systems. Gene Ther. 11 (2004) 649-657
40. Collins L., and Fabre J.W. A synthetic peptide vector system for optimal gene delivery to corneal endothelium. J. Gene Med. 6 (2004) 185-194
41. Medina-Kauwe L.K., Xie J., and Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 12 (2005) 1734-1751
42. Arenas E., Akerud P., Wong V., Boylan C., Persson H., Lindsay R.M., and Altar C.A. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo. Eur. J. Neurosci. 8 (1996) 1707-1717
43. Mendez M., Souaze F., Nagano M., Kelly P.A., Rostene W., and Forgez P. High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR. J. Mol. Neurosci. 9 (1997) 93-102
44. Sacchetti P., Mitchell T.R., Granneman J.G., and Bannon M.J. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J. Neurochem. 76 (2001) 1565-1572
45. Beck C., Uramoto H., Boren J., and Akyurek L.M. Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges. Curr. Gene Ther. 4 (2004) 457-467